Intelligo

Private limited company · Karmøy

ALGINOR PHARMA INGREDIENTS AS

ActiveManufacture of pharmaceutical preparations (21.200)

Founded
30 Dec 2021
Chief executive
Peer Bjerkvig Lea
Business address
Husøyvegen 260, 4262 Avaldsnes

The life line 2021–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2022: NOK 400k.

  1. Chair took office§ 07
  2. Managing director took office§ 07
  3. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

ALGINOR PHARMA INGREDIENTS AS is a private limited company in Karmøy, founded in 2021, in the industry manufacture of pharmaceutical preparations. The chief executive is Peer Bjerkvig Lea, and the chair of the board is Wenche Kjølås. In 2022 the company had NOK 400k in operating revenue and a net profit of NOK −89k. The largest owner is ALGINOR ASA with 100.0%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 30 Sep 2026

  • Endring av daglig leder
  • Annual accounts filed 2024 → 2025
  • Godkjent årsregnskap
  • Endring av styre

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

4 points

  • NoteOperating loss three years running, 2023–2025
  • NoteChanged auditor 2 May 2026
  • Note5 of 5 on the board are new in the last 12 months
  • OKEquity ratio 95.3%, above the industry median

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue — in 2025

Revenue

—

— from 2024

20232025

Operating profit

NOK −27.0m

−8,428.6% from 2024

20232025

Net profit

NOK −27.0m

−11,745.1% from 2024

20232025

Equity

NOK 44k

−99.5% from 2024

20232025

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2022

Of every krone of operating revenue in 2022:

  • Operating costs 122%

Costs exceeded revenue: the operating result was NOK −89k.

Source: the Register of Company Accounts, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 95.3%

RevenueNOK 400k Operating margin−22.2% Equity ratio95.3%
  • ALGINOR PHARMA INGREDIENTS AS, 2022
  • Industry median, assumed: NOK 20.7m · −18.9% · 44.8%

Equity NOK 9.9m95% of the assets (NOK 10.4m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 20 companies in 21.200 Manufacture of pharmaceutical preparations, not stated by the source.

Finances

§ 06 Accounts

5 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue———
Operating profit−27,044−317−55
Profit before tax−27,037−22893
Net profit−27,037−22892
Total assets22,50433,03818,765
Equity449,77210,000
Liabilities22,45923,2668,765

Source: the Register of Company Accounts, read 15 Nov 2026 · All 5 years →

Management and ownership

§ 07 Officers

7 officers now

The board: 5 members

Source: the Brønnøysund Register Centre, read 1 Oct 2026 · All 7 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

May sign for the company:

Styrets leder og ett styremedlem i fellesskap. Daglig leder og styrets leder i fellesskap.

Power of procuration:

Daglig leder alene.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 5 Oct 2026

Management and ownership

§ 09 Owners

1 shareholder · largest 100.0%

OwnerShare
ALGINOR ASA
100.0%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 1 owners →

Management and ownership

§ 10 Group

None registered

Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.

Management and ownership

§ 11 Portfolio

None registered

No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.

Management and ownership

§ 12 Network

118 connections

  • Person
  • Company

6 people link ALGINOR PHARMA INGREDIENTS AS to 65 other companies: Kristine Klaveness 30, Sten Stenersen 23, Wenche Kjølås 22, Per Arthur Sørlie 18, Martin Lersch 13 and Peer Bjerkvig Lea 10.

Source: the Brønnøysund Register Centre, read 1 Oct 2026 · Explore the network →

Events and registers

§ 13 Events

28 since 2021

Events per year

20212026

  • Notices27
  • Register changes1

Since 2021: 27 announcements and 1 register change. Most happened in 2022 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 28 events →

Events and registers

§ 14 Notices

27, latest 30 Sep 2026

  • Daglig leder
  • Godkjente årsregnskap
  • Styre

Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 27 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 11 Jan 2022
  • VATRegistered
  • The Register of Business EnterprisesRegistered 11 Jan 2022
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Bedriftsrådgivning, forretningsutvikling, investering, forskning og utvikling, innovasjon, produksjon, handel og distribusjon.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

None registered

No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 21.200

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

7 questions

  • Who is the chief executive of ALGINOR PHARMA INGREDIENTS AS?
    Peer Bjerkvig Lea, since 2026. § 07
  • Who owns ALGINOR PHARMA INGREDIENTS AS?
    1 shareholder. It is ALGINOR ASA with 100.0%. § 09
  • What was the revenue in 2022?
    NOK 400k in the company. § 06
  • Who can sign for ALGINOR PHARMA INGREDIENTS AS?
    Styrets leder og ett styremedlem i fellesskap. Daglig leder og styrets leder i fellesskap. § 08
  • Who is the auditor?
    CEDRA NORGE AS, from 2 May 2026. § 07
  • Where is ALGINOR PHARMA INGREDIENTS AS based?
    Husøyvegen 260, 4262 Avaldsnes.
  • When was ALGINOR PHARMA INGREDIENTS AS founded?
    30 Dec 2021, registered in the Register of Business Enterprises 11 Jan 2022. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose